Skip to main content
Menu
Public Information Hub
About Us
BAPRAS Information
About plastic surgery
Patient Information
Procedure Guides
News and Views
Professionals
Training and Education
Prizes, grants and fellowships
Research
Clinical Guidance and Regulations
JPRAS & JPRAS Open
e-LPRAS
UK National Flap Registry
Become a Member
Training and Education
Upcoming courses and events
BAPRAS Events
About Us
Find a Unit
Find a Member
Member Log in
Search
Home
Media & Government
News and Views
BAPRAS welcomes the success of the 80% facial transplant in the US.
BAPRAS welcomes the success of the 80% facial transplant in the US.
6
th
May 2009
BAPRAS has welcomed the success of the 80% facial transplant in the US. Improvements in techniques and medical research mean that the UK is ready to conduct a face transplant when the right donor and candidate are found.
Commenting on the completion of the face transplant for Connie Culp in the US, Hamish Laing, consultant plastic surgeon and spokesperson for the British Association of Plastic, Reconstructive and Aesthetic Surgeons, said:
“This case is particularly significant as it’s the world’s first near total facial transplant. Developments in plastic surgery and immunology techniques mean that something as this is now possible. Face transplants can give back a life to a patient who has been horribly scarred by burns, tumour or trauma as in this case.
“However, we must acknowledge the long-term medical risks, such as transplant rejection and the need for life-long medication, associated with the procedure. There is also the potential of psychological impact following such a transplant.
“As with any surgery, it must be in the patient’s best interest and it is only when an appropriate patient and donor have been found, that the first UK facial transplant will take place.
“The plastic surgery team at The Royal Free Hospital London, led by BAPRAS member Professpr Peter Butler have carefully investigated the risks associated with this procedure and have been given ethical approval to proceed pending patient need and a suitable donor.”
Back to list page
News and Views